Aggarwal Gaurav Insider Trades

Insider Trading History

Track insider trading activity for Aggarwal Gaurav. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Director
Holding Value $13.3M 1,789,915 shares
Last Trade
Aug 25, 2025 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$2.8M 652,900 shares
$4.29
$7.43
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Director
Holding Value $0 0 shares
Last Trade
Aug 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$13.7k 3,199 shares
$4.29
$7.43
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Director
Holding Value $291k 39,200 shares
Last Trade
Jul 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99.9k 21,200 shares
$4.71
$7.43
Geron
Geron GERN
Director
Holding Value $218k 180,000 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$241k 180,000 shares
$1.34
$1.21
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Director
Holding Value $84.5M 11,370,152 shares
Last Trade
Feb 18, 2025 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$8.67M 1,400,000 shares
$6.19
$7.43
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Director
Holding Value $23.2k 3,119 shares
Last Trade
Feb 18, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.25k 686 shares
$6.19
$7.43
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Director
Holding Value $74.1M 9,970,152 shares
Last Trade
Oct 09, 2024 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$19.9M 5,500,000 shares
$3.62
$7.43
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Director
Holding Value $28.9k 3,885 shares
Last Trade
Oct 09, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$9.76k 2,695 shares
$3.62
$7.43
Geron
Geron GERN
Director
Holding Value $218k 180,000 shares
Last Trade
May 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$698k 180,000 shares
$3.88
$1.21
Geron
Geron GERN
Director
Holding Value $2.38k 1,970 shares
Last Trade
Dec 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.16k 1,970 shares
$2.11
$1.21
Geron
Geron GERN
Director
Holding Value $242k 200,000 shares
Last Trade
Nov 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$394k 200,000 shares
$1.97
$1.21
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Director
Holding Value $1.34M 180,000 shares
Last Trade
Sep 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.37M 180,000 shares
$7.60
$7.43
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Director
Holding Value $138M 18,621,655 shares
Last Trade
Jul 11, 2023 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$525M 43,062,577 shares
$12.20
$7.43
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Director
Holding Value $0 0 shares
Last Trade
Jul 11, 2023 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$98.5k 8,077 shares
$12.20
$7.43
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Director
Holding Value $60k 8,077 shares
Last Trade
Mar 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$131k 8,077 shares
$16.20
$7.43

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up